| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C.N.R. Institute of Clinical Physiology and Department of Internal Medicine, University of Pisa, 56126 Pisa, Italy
This article has been cited by other articles:
![]() |
D. A. Nugent, D. M. Smith, and H. B. Jones A Review of Islet of Langerhans Degeneration in Rodent Models of Type 2 Diabetes Toxicol Pathol, June 1, 2008; 36(4): 529 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vaxillaire and P. Froguel Monogenic Diabetes in the Young, Pharmacogenetics and Relevance to Multifactorial Forms of Type 2 Diabetes Endocr. Rev., May 1, 2008; 29(3): 254 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Muscelli, A. Mari, A. Casolaro, S. Camastra, G. Seghieri, A. Gastaldelli, J. J. Holst, and E. Ferrannini Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients Diabetes, May 1, 2008; 57(5): 1340 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Holmberg, P. M. Nilsson, J-A. Nilsson, and K. Akesson The Association between Hyperglycemia and Fracture Risk in Middle Age. A Prospective, Population-Based Study of 22,444 Men and 10,902 Women J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 815 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1590 - E1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Ford, B. W. Hess, M. M. Schwope, M. J. Nijland, J. S. Gilbert, K. A. Vonnahme, W. J. Means, H. Han, and P. W. Nathanielsz Maternal undernutrition during early to mid-gestation in the ewe results in altered growth, adiposity, and glucose tolerance in male offspring J Anim Sci, May 1, 2007; 85(5): 1285 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. An, Y. Rhee, S. H. Kim, D. M. Kim, D.-H. Han, J. H. Hwang, Y.-J. Jin, B. S. Cha, J.-H. Baik, W. T. Lee, et al. Peripheral Effect of {alpha}-Melanocyte-stimulating Hormone on Fatty Acid Oxidation in Skeletal Muscle J. Biol. Chem., February 2, 2007; 282(5): 2862 - 2870. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buteau, A. Shlien, S. Foisy, and D. Accili Metabolic Diapause in Pancreatic beta-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1 J. Biol. Chem., January 5, 2007; 282(1): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. A. Black, M. Spence, R. O. McMahon, G. J. Cuskelly, C. N. Ennis, D. R. McCance, I. S. Young, P. M. Bell, and S. J. Hunter Effect of Eucaloric High- and Low-Sucrose Diets With Identical Macronutrient Profile on Insulin Resistance and Vascular Risk: A Randomized Controlled Trial Diabetes, December 1, 2006; 55(12): 3566 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. ADEGHATE, P. SCHATTNER, and E. DUNN An Update on the Etiology and Epidemiology of Diabetes Mellitus Ann. N.Y. Acad. Sci., November 1, 2006; 1084(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang and W. E Hoy Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians Int. J. Epidemiol., October 1, 2006; 35(5): 1331 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leipold, M. Knoefler, C. Gruber, K. Klein, P. Haslinger, and C. Worda Plasminogen activator inhibitor 1 gene polymorphism and gestational diabetes mellitus. Obstet. Gynecol., March 1, 2006; 107(3): 651 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Krukowska, I. Kinalska, and M. Gorska Plasma adiponectin concentration and tumor necrosis factor-{alpha} system activity in lean non-diabetic offspring of type 2 diabetic subjects Eur. J. Endocrinol., February 1, 2006; 154(2): 319 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leipold, M. Knoefler, C. Gruber, A. Huber, P. Haslinger, and C. Worda Peroxisome Proliferator-Activated REceptor {gamma} Coactivator-1{alpha} Gene Variations Are Not Associated With Gestational Diabetes Mellitus Reproductive Sciences, February 1, 2006; 13(2): 104 - 107. [Abstract] [PDF] |
||||
![]() |
R. J. Comi Treatment of Type 2 Diabetes Mellitus: A Weighty Enigma Ann Intern Med, October 18, 2005; 143(8): 609 - 610. [Full Text] [PDF] |
||||
![]() |
A. H. Brantsma, S. J.L. Bakker, H. L. Hillege, D. de Zeeuw, P. E. de Jong, R. T. Gansevoort, and the PREVEND Study Group Urinary Albumin Excretion and Its Relation With C-Reactive Protein and the Metabolic Syndrome in the Prediction of Type 2 Diabetes Diabetes Care, October 1, 2005; 28(10): 2525 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, J. L. Kuk, L. E. Davidson, R. Hudson, K. Kilpatrick, T. E. Graham, and R. Ross Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes J Appl Physiol, September 1, 2005; 99(3): 1220 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Dokken, J. A. Sloniger, and E. J. Henriksen Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1188 - E1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mari, A. Gastaldelli, J. E. Foley, R. E. Pratley, and E. Ferrannini {beta}-Cell Function in Mild Type 2 Diabetic Patients: Effects of 6-month glucose lowering with nateglinide Diabetes Care, May 1, 2005; 28(5): 1132 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kimmel and S. E. Inzucchi Oral Agents for Type 2 Diabetes: An Update Clin. Diabetes, April 1, 2005; 23(2): 64 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mari, A. Gastaldelli, A. Natali, T. Ostergard, O. Schmitz, and E. Ferrannini Characterization of {beta}-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E541 - E546. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lyssenko, P. Almgren, D. Anevski, R. Perfekt, K. Lahti, M. Nissen, B. Isomaa, B. Forsen, N. Homstrom, C. Saloranta, et al. Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes Diabetes, January 1, 2005; 54(1): 166 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Henquin Pathways in Beta-Cell Stimulus-Secretion Coupling as Targets for Therapeutic Insulin Secretagogues Diabetes, December 1, 2004; 53(suppl_3): S48 - S58. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marchetti, S. Del Guerra, L. Marselli, R. Lupi, M. Masini, M. Pollera, M. Bugliani, U. Boggi, F. Vistoli, F. Mosca, et al. Pancreatic Islets from Type 2 Diabetic Patients Have Functional Defects and Increased Apoptosis That Are Ameliorated by Metformin J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5535 - 5541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caumo and L. Luzi First-phase insulin secretion: does it exist in real life? Considerations on shape and function Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Oh, Y. S. Hong, Y.-A. Sung, and E. Barrett-Connor Prevalence and Factor Analysis of Metabolic Syndrome in an Urban Korean Population Diabetes Care, August 1, 2004; 27(8): 2027 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leipold, M. Knofler, C. Gruber, P. Haslinger, D. Bancher-Todesca, and C. Worda Calpain-10 Haplotype Combination and Association With Gestational Diabetes Mellitus Obstet. Gynecol., June 1, 2004; 103(6): 1235 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Degn, C. B. Juhl, J. Sturis, G. Jakobsen, B. Brock, V. Chandramouli, J. Rungby, B. R. Landau, and O. Schmitz One Week's Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and {alpha}- and {beta}-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes Diabetes, May 1, 2004; 53(5): 1187 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Straczkowski, I. Kowalska, A. Nikolajuk, S. Dzienis-Straczkowska, I. Kinalska, M. Baranowski, M. Zendzian-Piotrowska, Z. Brzezinska, and J. Gorski Relationship Between Insulin Sensitivity and Sphingomyelin Signaling Pathway in Human Skeletal Muscle Diabetes, May 1, 2004; 53(5): 1215 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wilkin, J. Ludvigsson, C. Greenbaum, J. Palmer, D. Becker, and J. Bruining Future Intervention Trials in Type 1 Diabetes Diabetes Care, April 1, 2004; 27(4): 996 - 997. [Full Text] [PDF] |
||||
![]() |
M. C. Sugden and M. J. Holness Potential Role of Peroxisome Proliferator-Activated Receptor-{alpha} in the Modulation of Glucose-Stimulated Insulin Secretion Diabetes, February 1, 2004; 53(90001): S71 - 81. [Abstract] [Full Text] |
||||
![]() |
M. Maliqueo, I. Atwater, R. Lahsen, F. Perez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of {beta}-cell dysfunction? Hum. Reprod., December 1, 2003; 18(12): 2683 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Zhao, F. M.M. Lai, P. C.Y. Tong, D.-R. Zhong, D. Yang, B. Tomlinson, and J. C.N. Chan Prevalence and Clinicopathological Characteristics of Islet Amyloid in Chinese Patients With Type 2 Diabetes Diabetes, November 1, 2003; 52(11): 2759 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ferrannini, A. Gastaldelli, M. Matsuda, Y. Miyazaki, M. Pettiti, L. Glass, and R. A. DeFronzo Influence of Ethnicity and Familial Diabetes on Glucose Tolerance and Insulin Action: A Physiological Analysis J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3251 - 3257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Thamer, M. Stumvoll, A. Niess, O. Tschritter, M. Haap, R. Becker, F. Shirkavand, O. Bachmann, K. Rett, A. Volk, et al. Reduced Skeletal Muscle Oxygen Uptake and Reduced {beta}-Cell Function: Two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes Diabetes Care, July 1, 2003; 26(7): 2126 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Torsoni, J. B. Carvalheira, M. Pereira-Da-Silva, M. A. de Carvalho-Filho, M. J. A. Saad, and L. A. Velloso Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E216 - E223. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Wolever and C. Mehling Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance Am. J. Clinical Nutrition, March 1, 2003; 77(3): 612 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.G. Hanley, K. Williams, C. Gonzalez, R. B. D'Agostino Jr, L. E. Wagenknecht, M. P. Stern, and S. M. Haffner Prediction of Type 2 Diabetes Using Simple Measures of Insulin Resistance: Combined Results From the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study Diabetes, February 1, 2003; 52(2): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Bonadonna, M. Stumvoll, A. Fritsche, M. Muggeo, H. Haring, E. Bonora, and T. W. van Haeften Altered Homeostatic Adaptation of First- and Second-Phase {beta}-Cell Secretion in the Offspring of Patients With Type 2 Diabetes: Studies With a Minimal Model to Assess {beta}-Cell Function Diabetes, February 1, 2003; 52(2): 470 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Laaksonen, H.-M. Lakka, L. K. Niskanen, G. A. Kaplan, J. T. Salonen, and T. A. Lakka Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort Study Am. J. Epidemiol., December 1, 2002; 156(11): 1070 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E Lebovitz Review: Type 2 diabetes: how far have we come? The British Journal of Diabetes & Vascular Disease, November 1, 2002; 2(6): 446 - 449. [Abstract] [PDF] |
||||
![]() |
P. Iozzo, P. Chareonthaitawee, D. Dutka, D. J. Betteridge, E. Ferrannini, and P. G. Camici Independent Association of Type 2 Diabetes and Coronary Artery Disease With Myocardial Insulin Resistance Diabetes, October 1, 2002; 51(10): 3020 - 3024. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Anderwald, E. Bernroider, M. Krssak, H. Stingl, A. Brehm, M. G. Bischof, P. Nowotny, M. Roden, and W. Waldhausl Effects of Insulin Treatment in Type 2 Diabetic Patients on Intracellular Lipid Content in Liver and Skeletal Muscle Diabetes, October 1, 2002; 51(10): 3025 - 3032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.G. Hanley, A. J. Karter, A. Festa, R. D'Agostino Jr., L. E. Wagenknecht, P. Savage, R. P. Tracy, M. F. Saad, and S. Haffner Factor Analysis of Metabolic Syndrome Using Directly Measured Insulin Sensitivity: The Insulin Resistance Atherosclerosis Study Diabetes, August 1, 2002; 51(8): 2642 - 2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
F X. Pi-Sunyer Glycemic index and disease Am. J. Clinical Nutrition, July 1, 2002; 76(1): 290S - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vrbikova, B. Bendlova, M. Hill, M. Vankova, K. Vondra, and L. Starka Insulin Sensitivity and {beta}-Cell Function in Women With Polycystic Ovary Syndrome Diabetes Care, July 1, 2002; 25(7): 1217 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Attele, Y.-P. Zhou, J.-T. Xie, J. A. Wu, L. Zhang, L. Dey, W. Pugh, P. A. Rue, K. S. Polonsky, and C.-S. Yuan Antidiabetic Effects of Panax ginseng Berry Extract and the Identification of an Effective Component Diabetes, June 1, 2002; 51(6): 1851 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marchetti, R. Lupi, M. Federici, L. Marselli, M. Masini, U. Boggi, S. Del Guerra, G. Patane, S. Piro, M. Anello, et al. Insulin Secretory Function Is Impaired in Isolated Human Islets Carrying the Gly972->Arg IRS-1 Polymorphism Diabetes, May 1, 2002; 51(5): 1419 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.G. Hanley, R. D'Agostino Jr., L. E. Wagenknecht, M. F. Saad, P. J. Savage, R. Bergman, and S. M. Haffner Increased Proinsulin Levels and Decreased Acute Insulin Response Independently Predict the Incidence of Type 2 Diabetes in the Insulin Resistance Atherosclerosis Study Diabetes, April 1, 2002; 51(4): 1263 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Inzucchi Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review JAMA, January 16, 2002; 287(3): 360 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M. S. Wolever, J. Kwan, and B. Zinman Cross-Sectional and Prospective Associations between Abdominal Adiposity and Proinsulin Concentration J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. CANAPLE, N. NURDIN, N. ANGELOVA, D. HUNKELER, and B. DESVERGNE Development of a Coculture Model of Encapsulated Cells Ann. N.Y. Acad. Sci., November 1, 2001; 944(1): 350 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stumvoll, H. G. Wahl, S. Jacob, A. Rettig, F. Machicao, and H. Haring Two novel prevalent polymorphisms in the hormone-sensitive lipase gene have no effect on insulin sensitivity of lipolysis and glucose disposal J. Lipid Res., November 1, 2001; 42(11): 1782 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kahn The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058. [Full Text] [PDF] |
||||
![]() |
E. Rask, T. Olsson, S. Soderberg, O. Johnson, J. Seckl, J. J. Holst, and B. Ahren Impaired Incretin Response After a Mixed Meal Is Associated With Insulin Resistance in Nondiabetic Men Diabetes Care, September 1, 2001; 24(9): 1640 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Federici, M. Hribal, L. Perego, M. Ranalli, Z. Caradonna, C. Perego, L. Usellini, R. Nano, P. Bonini, F. Bertuzzi, et al. High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans: A Potential Role for Regulation of Specific Bcl Family Genes Toward an Apoptotic Cell Death Program Diabetes, June 1, 2001; 50(6): 1290 - 1301. [Abstract] [Full Text] |
||||
![]() |
A. Antonelli, G. Baj, P. Marchetti, P. Fallahi, N. Surico, C. Pupilli, F. Malavasi, and E. Ferrannini Human Anti-CD38 Autoantibodies Raise Intracellular Calcium and Stimulate Insulin Release in Human Pancreatic Islets Diabetes, May 1, 2001; 50(5): 985 - 991. [Abstract] [Full Text] |
||||
![]() |
R. Mallone, E. Ortolan, G. Baj, A. Funaro, S. Giunti, E. Lillaz, F. Saccucci, M. Cassader, P. Cavallo-Perin, and F. Malavasi Autoantibody Response to CD38 in Caucasian Patients With Type 1 and Type 2 Diabetes: Immunological and Genetic Characterization Diabetes, April 1, 2001; 50(4): 752 - 762. [Abstract] [Full Text] |
||||
![]() |
L. J. Bischof, C. C. Martin, C. A. Svitek, B. T. Stadelmaier, L. A. Hornbuckle, J. K. Goldman, J. K. Oeser, J. C. Hutton, and R. M. OBrien Characterization of the Mouse Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein Gene Promoter by In Situ Footprinting: Correlation With Fusion Gene Expression in the Islet-Derived {beta}TC-3 and Hamster Insulinoma Tumor Cell Lines Diabetes, March 1, 2001; 50(3): 502 - 514. [Abstract] [Full Text] |
||||
![]() |
S. P. Cousin, S. R. Hugl, C. E. Wrede, H. Kajio, M. G. Myers Jr., and C. J. Rhodes Free Fatty Acid-Induced Inhibition of Glucose and Insulin-Like Growth Factor I-Induced Deoxyribonucleic Acid Synthesis in the Pancreatic {beta}-Cell Line INS-1 Endocrinology, January 1, 2001; 142(1): 229 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weyer, P. A. Tataranni, C. Bogardus, and R. E. Pratley Insulin Resistance and Insulin Secretory D |